Bristol-Myers Squibb (BMY) Declares $0.40 Quarterly Dividend; 2.6% Yield

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. SPCX
2. HUM
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. SBUX
9. AXP
10. ZETA

Go back to Bristol-Myers Squibb (BMY) Declares $0.40 Quarterly Dividend; 2.6% Yield

Bristol-Myers Squibb (BMY) Reports 'Significant Skin Clearance' from Phase 2 Study of BMS-986165 in Patients with Moderate to Severe Plaque Psoriasis

September 12, 2018 5:59 AM EDT

Bristol-Myers Squibb Company (NYSE: BMY) today announced results from a Phase 2 study of BMS-986165, an investigational oral, selective tyrosine kinase 2 (TYK2) inhibitor, in patients with moderate to severe plaque psoriasis. Efficacy endpoints including 75% and 90% reduction in the Psoriasis Area and Severity Index (PASI 75, PASI 90) were achieved following 12 weeks of treatment with 3 mg daily of BMS-986165, with a... More